AviadoBio broadens vMiX gene silencing licence with King’s College London
The expanded licensing lets AviadoBio pursue partnerships for broader applications, including cardiovascular, nephrology, oncology, and beyond the CNS.
Drug Development
Zai Lab’s zocilurtatug pelitecan secures EMA orphan drug status
Alkermes’ alixorexton secures FDA and EC orphan designations
Simcere and Stanford partner to develop IPF therapies
FDA clears MSD’s Keytruda combo plus Welireg for ccRCC treatment
China’s NMPA approves Akeso’s gumokimab for plaque psoriasis
FDA grants priority review for Roche’s Tecentriq combo sBLA
XtalPi enters $400m partnership for small molecule therapy for GPCR target
